2
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Head & Neck
1
Gastrointestinal
1
Conditions
Uterine Cervical Neoplasms
10
Neoplasms
9
Breast Neoplasms
9
Colorectal Neoplasms
8
Lung Neoplasms
5
Papillomavirus Infections
3
Uterine Cervical Dysplasia
2
Prostatic Neoplasms
2
Pancreatic Neoplasms
2
Neoplasm Metastasis
2
Heart Diseases
2
HIV Infections
2
Gastrointestinal Neoplasms
2
Esophageal Neoplasms
2
End Stage Liver Disease
2
the Rate of Participation in Screening for PBC
1
Warts
1
Venous Thromboembolism
1
Uterine Cervical Diseases
1
Urinary Bladder Neoplasms
1
Tinea
1
Squamous Intraepithelial Lesions
1
Squamous Cell Carcinoma of Head and Neck
1
Smoking
1
Skin Neoplasms
1
Retinoblastoma
1
Radiation Injuries
1
Pulmonary Atelectasis
1
Postural Orthostatic Tachycardia Syndrome
1
Postoperative Complications
1
Interventions
Cisplatin
258
Radiotherapy
193
Cetuximab
151
pembrolizumab
123
Docetaxel
97
Fluorouracil
92
Carboplatin
80
Paclitaxel
78
Radiotherapy, Intensity-Modulated
72
Surveys and Questionnaires
46
Nivolumab
42
Drug Therapy
34
Radiation
33
Blood Specimen Collection
27
Erlotinib Hydrochloride
26
Gemcitabine
25
Immunohistochemistry
22
Gefitinib
22
Cyclophosphamide
22
Surgical Procedures, Operative
21
Standard of Care
20
durvalumab
19
Pemetrexed
19
Magnetic Resonance Spectroscopy
19
Radiosurgery
17
Capecitabine
17
Chemotherapy, Adjuvant
16
Celecoxib
16
Biopsy
16
atezolizumab
15
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Head and Neck Neoplasms
×
Mass Screening
×
Clear all
NCT04379232
2020-05-07
SurgiCovid
Hospices Civils de Lyon
Completed
112 enrolled